Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS With Real-time E-field and EEG Source Imaging

NCT: NCT06645613 · ACTIVE_NOT_RECRUITING

NCT IDNCT06645613
StatusACTIVE_NOT_RECRUITING
Start Date2026-03-01
Completion2029-09-01

Brief Summary

The goal of this study is to develop and validate an approach for accurate targeting and stimulation of brain networks using transcranial magnetic stimulation (TMS) using information from magnetic resonance imaging (MRI) data. This study requires two visits from each participant. In the first visit, the participant will be scanned by MRI scanners to collect data from the brain. Next, the data will be analyzed by the researcher to model the connections between different regions of the brain to determine the stimulation areas related to the so-called frontoparietal network. In the second visit, the participants will take four TMS sessions with different types of stimulations applied to the computed targets and complete a computer-based task named multi-source interference task. Electroencephalogram (EEG) data will be collected during the TMS stimulations and tasks. The main hypothesis is that applying TMS stimulations to the brain targets reduces the response time and response error in the tasks.

Frequently Asked Questions

What is TMS With Real-time E-field and EEG Source Imaging?

TMS With Real-time E-field and EEG Source Imaging is a clinical trial registered under NCT06645613. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06645613?

The current status of NCT06645613 (TMS With Real-time E-field and EEG Source Imaging) is: ACTIVE_NOT_RECRUITING.

When did TMS With Real-time E-field and EEG Source Imaging start?

TMS With Real-time E-field and EEG Source Imaging started on 2026-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.